Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1997-5-19
|
pubmed:abstractText |
TCR engagement leads to down-modulation of TCR/CD3 complexes from the T cell surface. The importance of this effect in T cell physiology is unknown. Here, we characterized a CTL clone deficient in TCR/CD3 surface expression that had lost both CD3delta and CD3gamma mRNA, allowing us to address the role of these chains in the assembly, signaling, and dynamics of the TCR/CD3 complex. Expression of either CD3delta or CD3gamma alone failed to reconstitute surface expression of the TCR/CD3 complex, but reconstitution with a cytoplasmically truncated CD3delta (delta t) and a native (gamma) or cytoplasmically truncated (gamma t) human CD3gamma led to reexpression of TCR/CD3 complexes in both cases. This indicated that CD3delta and CD3gamma assume specific functions in TCR/CD3 assembly independently of their cytoplasmic domains. The delta t gamma t variant specifically killed target cells, expressed the IFN-gamma gene in response to Ag, and produced TNF-alpha in response to anti-CD3 mAb, but it was affected in CD3 ligand-induced TCR/CD3 down-modulation. Both PMA- and CD3 ligand-induced TCR/CD3 down-modulation were defective in the delta t gamma t variant, whereas the delta t gamma variants were unaffected, and previously described delta gamma t variants were affected only in PMA-induced down-modulation. Specific protein kinase C (PKC) inhibitors indicated that PMA- but not CD3 ligand-induced down-modulation was dependent on PKC activity. Thus, amino acid sequences present in either the CD3delta or CD3gamma cytoplasmic domain control ligand-induced TCR/CD3 down-modulation, and neither these sequences nor this property are required for cytolysis and IFN-gamma gene expression in response to Ag.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4162-70
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9126976-Animals,
pubmed-meshheading:9126976-Antigens, CD3,
pubmed-meshheading:9126976-Cell Line,
pubmed-meshheading:9126976-Cell Separation,
pubmed-meshheading:9126976-Cytoplasm,
pubmed-meshheading:9126976-Cytotoxicity, Immunologic,
pubmed-meshheading:9126976-Down-Regulation,
pubmed-meshheading:9126976-Mice,
pubmed-meshheading:9126976-Mice, Inbred C57BL,
pubmed-meshheading:9126976-Mice, Inbred CBA,
pubmed-meshheading:9126976-Microscopy, Confocal,
pubmed-meshheading:9126976-Protein Kinase C,
pubmed-meshheading:9126976-Receptors, Antigen, T-Cell,
pubmed-meshheading:9126976-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:9126976-Tetradecanoylphorbol Acetate,
pubmed-meshheading:9126976-Time Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation.
|
pubmed:affiliation |
Center of Immunology, INSERM-CNRS of Marseille-Luminy, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|